BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37774081)

  • 21. Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition.
    Hosseini M; Baghaei K; Amani D; Ebtekar M
    Daru; 2021 Dec; 29(2):267-278. PubMed ID: 34405380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
    Duan Z; Choy E; Harmon D; Liu X; Susa M; Mankin H; Hornicek F
    Mol Cancer Ther; 2011 Aug; 10(8):1337-45. PubMed ID: 21666078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of miR-29 and STAT3 in osteosarcoma and its effect on proliferation regulation of osteosarcoma cells.
    Li MH; Wu ZY; Wang Y; Chen FZ; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7275-7282. PubMed ID: 31539114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
    Li P; Shi X; Xu Y; Zhong B; Lu Y; Sun Y
    Med Sci Monit; 2018 Nov; 24():7802-7808. PubMed ID: 30381753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
    Sun Z; Zhang T; Chen B
    Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.
    Wu X; Zhong D; Gao Q; Zhai W; Ding Z; Wu J
    Int J Med Sci; 2013; 10(6):676-82. PubMed ID: 23569431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-34b Alleviates High Glucose-Induced Inflammation and Apoptosis in Human HK-2 Cells via IL-6R/JAK2/STAT3 Signaling Pathway.
    Lv N; Li C; Liu X; Qi C; Wang Z
    Med Sci Monit; 2019 Oct; 25():8142-8151. PubMed ID: 31665127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
    Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
    Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
    Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.
    Horiuchi S; Yamamoto N; Dewan MZ; Takahashi Y; Yamashita A; Yoshida T; Nowell MA; Richards PJ; Jones SA; Yamamoto N
    Int J Cancer; 2006 Aug; 119(4):823-30. PubMed ID: 16557588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
    Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
    BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
    Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
    FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma.
    Deng N; Li L; Gao J; Zhou J; Wang Y; Wang C; Liu Y
    Biochem Biophys Res Commun; 2018 Jan; 495(1):189-196. PubMed ID: 29117539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation.
    Yang M; Zhang Y; Liu G; Zhao Z; Li J; Yang L; Liu K; Hu W; Lou Y; Jiang J; Liu Q; Zhao P
    Cell Death Dis; 2022 Sep; 13(9):815. PubMed ID: 36151091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulatory role of aberrant methylation of microRNA-34a promoter CpGs in osteosarcoma.
    Shi J; Zhao C; Liu X; Zhang B; Wang P; Yang Z; Niu N
    Transl Cancer Res; 2019 Oct; 8(6):2328-2338. PubMed ID: 35116985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-451a targeting IL-6R activates JAK2/STAT3 pathway, thus regulates proliferation and apoptosis of multiple myeloma cells.
    Xu L; Yao Y; Lu T; Jiang L
    J Musculoskelet Neuronal Interact; 2022 Jun; 22(2):251-260. PubMed ID: 35642704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
    Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
    PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.